Literature DB >> 6357914

Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects.

F J Service, L D Hall, R E Westland, P C O'Brien, V L Go, M W Haymond, R A Rizza.   

Abstract

The effects of size, time of day and sequence of meal ingestion were determined in healthy subjects using a Latin square design. Plasma glucose, insulin and gastric inhibitory polypeptide, but not glucagon, were correlated with meal size. Plasma glucose, but not insulin, gastric inhibitory polypeptide or glucagon, were greater later in the day. The progressive decline in carbohydrate tolerance from 08.00 to 18.00 h was associated with impaired insulin secretion estimated by C-peptide, and with impaired insulin action.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357914     DOI: 10.1007/bf00253193

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

Review 1.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

2.  Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects.

Authors:  M Ahmed; M C Gannon; F Q Nuttall
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

3.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

4.  Further observations on the diurnal variation in oral glucose tolerance.

Authors:  R J Jarrett; H Keen
Journal:  Br Med J       Date:  1970-11-07

5.  Comparison of the 50 and 100 gram oral glucose tolerance test.

Authors:  C W Sisk; C E Burnham; J Stewart; G W McDonald
Journal:  Diabetes       Date:  1970-11       Impact factor: 9.461

6.  Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.

Authors:  R L Nelson; F J Service; V L Go
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

7.  Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids.

Authors:  P Z Zimmet; J R Wall; R Rome; L Stimmler; R J Jarrett
Journal:  Br Med J       Date:  1974-03-16

8.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.

Authors:  R A Rizza; J E Gerich; M W Haymond; R E Westland; L D Hall; A H Clemens; F J Service
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

9.  Comparison of serum glucose, insulin, and glucagon responses to different types of complex carbohydrate in noninsulin-dependent diabetic patients.

Authors:  P A Crapo; J Insel; M Sperling; O G Kolterman
Journal:  Am J Clin Nutr       Date:  1981-02       Impact factor: 7.045

10.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  25 in total

1.  Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans.

Authors:  Christopher J Morris; Jessica N Yang; Joanna I Garcia; Samantha Myers; Isadora Bozzi; Wei Wang; Orfeu M Buxton; Steven A Shea; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Should the amounts of fat and protein be taken into consideration to calculate the lunch prandial insulin bolus? Results from a randomized crossover trial.

Authors:  José Manuel García-López; María González-Rodriguez; Marcos Pazos-Couselo; Francisco Gude; Alma Prieto-Tenreiro; Felipe Casanueva
Journal:  Diabetes Technol Ther       Date:  2012-12-21       Impact factor: 6.118

3.  Effect of an extra intake of carbohydrate at dinner on morning after fasting plasma glucose values in types I and II diabetes.

Authors:  J Belkhadir; T Rosset; F Elgrably; M Haardt; F Bornet; G Tchobroutsky; G Slama
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

4.  The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion.

Authors:  I R Jones; D R Owens; A J Moody; S D Luzio; T Morris; T M Hayes
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

5.  Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch.

Authors:  Mark Peyrot; Darlene Dreon; Vivien Zraick; Brett Cross; Meng H Tan
Journal:  Diabetes Ther       Date:  2018-01-11       Impact factor: 2.945

6.  Glucose metabolism during rotational shift-work in healthcare workers.

Authors:  Anu Sharma; Marcello C Laurenti; Chiara Dalla Man; Ron T Varghese; Claudio Cobelli; Robert A Rizza; Aleksey Matveyenko; Adrian Vella
Journal:  Diabetologia       Date:  2017-05-27       Impact factor: 10.122

7.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

8.  Overview of glycemic control in critical care: relating performance and clinical results.

Authors:  J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Jason Wong; Jessica Lin; Thomas Lotz; Aaron Lecompte; Timothy Lonergan
Journal:  J Diabetes Sci Technol       Date:  2007-01

9.  Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.

Authors:  E Van Cauter; J D Blackman; D Roland; J P Spire; S Refetoff; K S Polonsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

Authors:  S Dinneen; A Alzaid; J Miles; R Rizza
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.